Replies to post #250139 on Biotech Values

[midastouch017]

CGEN - Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

https://finance.yahoo.com/news/compugen-eligible-receive-10-million-121000149.html